Long-chain (n-3) PUFA exert beneficial effects on inflammatory bowel diseases in animal models and clinical trials. In addition, pattern recognition receptors such as toll-like receptors (TLR) and nucleotide-binding oligomerization domain proteins (NOD) play a critical role in intestinal inflammation. We hypothesized that fish oil could alleviate Escherichia coli LPS-induced intestinal injury via modulation of TLR4 and NOD signaling pathways. Twenty-four weaned piglets were used in a 2 3 2 factorial design and the main factors included a dietary treatment (5% corn oil or 5% fish oil) and immunological challenge (LPS or saline). After feeding fish oil or corn oil diets for 21 d, pigs were injected with LPS or saline. At 4 h postinjection, blood samples were collected and pigs were killed. EPA, DHA, and total (n-3) PUFA were enriched in intestinal mucosa through fish supplementation. Fish oil improved intestinal morphology, indicated by greater villus height and villus height:crypt depth ratio, and intestinal barrier function, indicated by decreased plasma diamine oxidase (DAO) activity and increased mucosal DAO activity as well as enhanced protein expression of intestinal tight junction proteins including occludin and claudin-1. Moreover, fish oil decreased intestinal TNFa and PGE 2 concentrations and caspase-3 and heat shock protein 70 protein expression. Finally, fish oil downregulated the mRNA expression of intestinal TLR4 and its downstream signals myeloid differentiation factor 88, IL-1 receptor-associated kinase 1, TNFa receptor-associated factor 6, and NOD2, and its adaptor molecule, receptor-interacting serine/threonine-protein kinase 2. Fish oil decreased the protein expression of intestinal NFkB p65. These results indicate that fish oil supplementation is associated with inhibition of TLR4 and NOD2 signaling pathways and concomitant improvement of intestinal integrity under an inflammatory condition.
Introduction
The intestinal tract is important as the first line of defense against bacteria-derived endogenous and exogenous harmful agents (1, 2) . However, numerous factors such as infection and inflammation lead to intestinal mucosal damage and dysfunction such as necrotizing enterocolitis (2) . Proinflammatory cytokines play a central role in intestinal mucosal disruption (3, 4) . Overproduction of proinflammatory cytokines leads to a breakdown in intestinal integrity and epithelial function (3) . Therefore, nutritional intervention of the production of intestinal proinflammatory cytokines may exert beneficial effects in attenuating the intestinal injury.
Long-chain (n-3) PUFA such as EPA [20:5(n-3) ] and DHA [22:6(n-3)], which are abundant in fish oil, have been used as immune modulators (5) (6) (7) (8) (9) . Research has shown that (n-3) PUFA exert beneficial effects on inflammatory bowel diseases in animal models and clinical trials (6) . Consequently, increased consumption of dietary (n-3) PUFA (especially EPA and DHA) has been recommended in most nutritional guidelines issued by government and health organizations (10) . The protective role of (n-3) PUFA in the intestine is closely related to their inhibitory effects on the over-release of intestinal proinflammatory cytokines (6) . However, the molecular mechanism(s) underlying this beneficial effect are poorly understood.
Pattern recognition receptors such as toll-like receptors (TLR) and nucleotide-binding oligomerization domain proteins (NOD) play a critical role in the detection of microbial infection and the induction of inflammatory and immune responses by recognizing pathogen-associated molecular patterns (PAMP) 6 (11) (12) (13) . Of them, TLR are localized either to the cell surface or within endosomes, whereas NOD are localized in cytoplasm. Activation of both TLR and NOD results in the activation of NFkB via multiple downstream intracellular signals (11) . Activated NFkB stimulates synthesis of proinflammatory cytokines, including TNFa, IL-1b, and IL-6 (11) . Consequently, the proinflammatory cytokines mediate the hostÕs defense against invading pathogens but also can elicit collateral host-tissue injury. Current research has implicated TLR4 and NOD signaling in multi-layered inflammatory intestinal diseases, where deregulation of the PAMP leads to acute and chronic intestinal inflammation that affects quality of life (14, 15) . Accordingly, we hypothesized that (n-3) PUFA supplementation would affect intestinal health by regulating the production of proinflammatory cytokines by influencing TLR and NOD signaling pathways. In the present study, Escherichia coli LPS, a potent endotoxin, was injected to build on our model of intestinal injury (16) . We employed a piglet model, a well-characterized animal model for studying infant nutrition and gastrointestinal physiology (17) , to elaborate whether fish oil [rich in (n-3) PUFA such as EPA and DHA] could attenuate LPS-induced intestinal injury via modulation of the TLR4 and NOD signaling pathways.
Materials and Methods
Pig care and diets. This experiment was approved by the Animal Care and Use Committee of Hubei Province, China. A total of 24 weaned barrows [Duroc 3 Large White 3 Landrace; 9.0 6 0.7 kg initial body weight (BW); weaned at 21 6 1 d of age] were randomly allotted to 4 groups. Pigs were individually housed in 1.80-3 1.10-m pens of an environmentally controlled, segregated nursery barn. There were 6 replicate pens for each treatment. Each pen contained a feeder and a nipple waterer to allow piglets ad libitum access to feed and water. The experimental diets differed according to the sources of oil: fish oil (menhaden fish oil, Fujian Gaolong) or corn oil (Xiwang Food). Diets (Supplemental Table 1 ) were formulated to meet or exceed NRC (18) requirements for all nutrients. The fatty acid composition (Table 1 ) of the fish oil-or corn oil-supplemented diets was analyzed by GC according to the method of Nieto et al. (19) . In the fish oil diet,~2.1% of the total energy came from EPA and 1.3% from DHA. This level of EPA/DHA corresponded to~7.6 g/d (n-3) PUFA consumed by a human on a daily basis (20) . This level is within the range used in human clinical trials [i.e., 1-9 g/d (n-3) PUFA, which corresponds to 0.45-4% of energy] and that consumed by Greenland Inuit [i.e., 6-14 g/d (n-3) PUFA, which corresponds to 2.7-6.3% of daily energy] (20) . This dose of fish oil can be considered as representative of the therapeutic dose for treating chronic diseases, such as inflammatory bowel diseases, rheumatoid arthritis, and asthma (20, 21) . The levels of crude protein, calcium, and phosphorus in the diets were measured in accordance with established procedures (22) .
Experimental design. The experiment was arranged as a 2 3 2 factorial design. The main factors included dietary treatment (pigs fed either 5% corn oil-or 5% fish oil-supplemented diets) and LPS challenge (pigs challenged with LPS or treated with sterile saline). On the morning of d 21, the challenged group was i.p. injected with Escherichia coli LPS (E. coli serotype 055: B5, Sigma Chemical) at 100 mg/kg BW and the unchallenged group was injected with the same amount of 0.9% NaCl solution. The dose of LPS was chosen in accordance with our previous study (16) . The pigs were weighed and feed consumption was recorded on d 1 and 21.
Blood and intestinal sample collections. Four hours following the injection with LPS or saline, blood samples were collected into heparinized vacuum tubes and centrifuged to separate plasma according to Liu et al. (23) . Plasma was stored at -80°C for further analysis of diamine oxidase (DAO). Following blood collection, all pigs were humanely killed and one intestinal segment measuring 3 cm in length and one measuring 10 cm were excised from the mid-jejunum and mid-ileum according to Liu et al. (16) . Previous studies have demonstrated that, within 3-6 h postinjection, LPS caused acute intestinal morphologic damage and a breakdown in intestinal barrier function in rats, mice, and pigs, which was associated with enhanced proinflammatory cytokine production (16, (24) (25) (26) (27) . Therefore, the time point of 4 h following LPS or saline injection was chosen for experimental measurements.
The 3-cm intestinal segments were flushed with ice-cold PBS and then fixed in 10% fresh, chilled formalin solution (16) . The 10-cm intestinal segments were opened longitudinally and the contents were flushed with ice-cold PBS. The mucosa samples were harvested by scraping with a glass slide, immediately frozen in liquid nitrogen, and then stored at 280°C for further analysis.
The frozen mucosa samples were weighed, homogenized, and centrifuged to collect the supernatant according to Liu et al. (16) . The supernatant was used for DAO, TNFa, and PGE 2 analysis (described below). The protein concentration of supernatant was determined according to the method of Lowry et al. (28) .
Intestinal mucosal fatty acid composition. Jejunal and ileal mucosa fatty acid profiles were analyzed according to the method of Nieto et al. (19) .
Intestinal morphology. After a 24-h fixation, the intestinal segments were dehydrated, embedded, and stained with hematoxylin and eosin according to the procedures of Luna (29) . The method for measurements of villus height, crypt depth, and villus height:crypt depth ratio (VCR) was according to Liu et al. (16) .
DAO activity in plasma and intestinal mucosa. The DAO activity in plasma and intestinal mucosa supernatant was measured in accordance with the method of Liu et al. (30) . The results of the measurements were expressed as U/L and U/mg protein, respectively.
TNFa and PGE 2 concentrations in intestinal mucosa. The TNFa and PGE 2 concentrations in intestinal mucosa supernatant were assayed according to Liu et al. (23) and the results were expressed as pg/mg protein.
Protein expression analysis by Western blot. The method for quantification of protein expression in intestinal mucosa was according to the procedures of Hou et al. (17, 31) . Briefly, the intestinal mucosa samples (100-150 mg) (n = 6) were homogenized in 1 mL of lysis buffer and centrifuged at 12,000 3 g for 15 min at 4°C. The supernatants were collected for Western blot and protein assay. Intestinal mucosa proteins (40-120 mg) were separated on a 10 or 12% polyacrylamide gel and transferred onto polyvinylidene difluoride membranes. Immunoblots were blocked with 3% BSA in 13Tris-buffered saline including 0.1% Tween 20 buffer for at least 60 min at room temperature and incubated overnight at 4°C with primary antibodies. Specific primary antibodies included rabbit anti-claudin-1 (1:1000; Invitrogen), mouse antioccludin (1:1000; Invitrogen), rabbit anti-caspase-3 (1:1000; Cell Signaling), mouse anti-HSP70 (1:2000; Stressgen), mouse anti-NFkB p65 (1:1000; Cell Signaling), or mouse anti-b-actin (1:10,000; Sigma Aldrich). The blots were washed 3 times with 13Tris-buffered saline including 0.1% Tween 20 for 5 min and incubated with anti-rabbit (or mouse) IgG HRP-conjugated secondary antibody (1:5000; Beijing ZhongShan Golden Bridge Biological Technology) for 120 min at room temperature. Membranes were washed 3 times with the same buffer for 10 min. Blots were developed using an Enhanced Chemiluminescence Western blotting kit (Amersham), visualized using a Gene Genome bioimaging system, and analyzed using GeneTools software (Syngene). The relative abundance of each target protein was expressed as the target protein:b-actin protein ratio. One sample from each treatment was run in duplicate in a gel and 24 samples from 4 treatments (n = 6) were run in 6 gels at one time to minimize the variations of gel to gel.
mRNA expression analysis by real-time PCR. Total RNA was extracted from intestinal mucosa (n = 6) using the TRIzol reagent [TaKaRa Biotechnology (Dalian)] according to the manufacturerÕs guidelines. RNA was spectrophotometrically quantified (A260) and its integrity was verified by agarose gel electrophoresis. Both genomic DNA removal and RT were performed using PrimeScript RT reagent kit with gDNA eraser [TaKaRa Biotechnology (Dalian)] according to the manufacturerÕs instructions.
Quantitative analysis of PCR was carried out on an ABI 7500 Real-Time PCR system (Applied Biosystems, Life Technologies) using a SYBR Premix Ex Taq (Tli RNaseH Plus) qPCR kit [TaKaRa Biotechnology (Dalian)]. The PCR reaction consisted of 10.0 mL SYBR Premix Ex Taq (23), 0.4 mL ROX reference dye II (103), 2.0 mL cDNA, 6.8 mL RNase free water, 0.4 mL forward primer (10 mmol/L), and 0.4 mL reverse primer (10 mmol/L) in a total volume of 20 mL. Cycling conditions were 95°C 3 30 s, followed by 40 cycles of 95°C 3 5 s and 60°C 3 34 s. The primer pairs used are presented in Supplemental Table 2 . The amplification efficiency of each primer pair was determined by the following procedures. Briefly, a cDNA preparation was conducted with seven 2-fold serial dilutions. Amplifications were performed using each primer pair for each dilution sample. A linear standard curve is constructed by plotting the log cDNA dilution factor compared with the C T value obtained during amplification of each dilution, and then the amplification efficiency of each primer pair was calculated from the slope of the standard curve using the formula: E = [10 (-1/slope) 2 1] 3100. The amplification efficiencies of all target genes and housekeeping gene used were close to 100%. Agarose gel electrophoresis and sequencing were conducted to verify the amplification products. Results were analyzed by the 2 -DDCT method of Livak and Schmittgen (32), with GAPDH as the housekeeping gene. Our results showed that GAPDH did not exhibit any variation with treatment and locations in small intestine. The relative mRNA abundance of each target gene was normalized to the corn oil group treated with sterile saline. All samples were run in triplicate.
Statistical analysis. All data were analyzed by ANOVA using the general linear model procedures of SAS appropriate for a 2 3 2 factorial design (SAS Institute). The statistical model included the effects of challenge (saline or LPS), diet (corn oil or fish oil), and their interactions. Data were reported as means 6 pooled SEM. When there was significant interaction or a trend for interaction, post hoc testing was conducted using BonferroniÕs multiple comparison test. P # 0.05 was considered significant. Instances in which 0.05 < P # 0.10 were discussed as trends.
Results
Performance. Throughout the 21-d trial (prechallenge), there were no differences in initial (9.0 6 0.7 kg) and final BW (19.9 6 1.0 kg), daily gain (519 6 26 g), daily feed intake (833 6 52 g), and the gain:feed ratio (0.62 6 0.02) between the fish oil-and corn oilsupplemented groups.
Fatty acid composition of intestinal mucosa. Pigs challenged with LPS tended to have a higher jejunal arachidonic acid [20:4(n-6)] proportion (P = 0.06) than pigs injected with saline ( Table 2) . No significant changes were observed for the other selected fatty acids in jejunum and ileum due to LPS challenge. Except ileal arachidonic acid, there was no LPS challenge 3 diet interaction observed for the proportions of the other selected fatty acids. Intestinal mucosa fatty acid profiles mostly reflected the dietary fatty acid composition (Tables 1 and 2 ). Relative to pigs fed corn oil, pigs fed fish oil had higher proportions of palmitoleic acid [16:1(n-7)], stearic acid (18:0), EPA, DHA, and total (n-3) PUFA and had lower proportions of linoleic acid [18:2(n-6)], arachidonic acid, total (n-6) PUFA, and (n-6):(n-3) ratio in jejunum and ileum (P < 0.01). The proportions of jejual and ileal palmitic acid (16:0) and oleic acid [18:1(n-9)] did not differ between the fish oil and corn oil diet groups.
Intestinal morphology. There was no LPS challenge 3 diet interaction observed for villus height, crypt depth, and VCR in jejunum and ileum ( Table 3) . Pigs challenged with LPS had lower villus height in jejunum (P < 0.001) and ileum (P < 0.05), lower VCR in jejunum (P < 0.001), and tended to have lower ileal VCR (P = 0.08) than those injected with saline. Relative to pigs fed corn oil, pigs fed fish oil had higher villus height in jejunum (P < 0.05) and ileum (P < 0.05), higher VCR in ileum (P < 0.01), and tended to had higher VCR in jejunum (P = 0.07). Neither LPS nor diet had an effect on crypt depth.
Blood and intestinal DAO activity. The pigs challenged with LPS had higher plasma DAO activity than pigs injected with saline (P < 0.01) ( Table 4) . A trend for a LPS challenge 3 diet interaction was observed for plasma DAO activity (P = 0.06) in which pigs fed fish oil had lower plasma DAO activity compared with pigs fed corn oil among LPS-treated pigs, whereas DAO did not differ among saline-treated pigs. No LPS challenge 3 diet interaction was observed for jejunal and ileal DAO activity. The pigs challenged with LPS had lower jejunal and ileal DAO activity than those injected with saline (P < 0.05); however, pigs fed fish oil had a higher jejunal DAO activity than those fed corn oil (P < 0.05).
Intestinal tight junction protein expression. There was no LPS challenge 3 diet interaction observed for occludin and claudin-1 ( Fig. 1; Table 4 ). Pigs challenged with LPS had lower jejunal occludin (P < 0.01), ileal occludin (P < 0.01), and claudin-1 (P = 0.05) expression than those injected with saline. The pig fed fish oil had higher protein expression of jejunal occludin (P = 0.05) and ileal claudin-1 (P = 0.05) and tended to have higher protein expression of ileal occludin (P = 0.06) compared with those fed corn oil. Neither LPS nor diet had an effect on jejunal claudin-1 protein expression.
Intestinal TNFa, PGE 2 , caspase-3, and HSP70. Compared with pigs injected with saline, pigs challenged with LPS had higher TNFa and PGE 2 concentrations (P < 0.05), caspase-3 (P < 0.01) protein expression in jejunum and ileum, and HSP70 protein expression in jejunum (P < 0.001) and tended to have higher HSP70 protein expression in ileum (P = 0.09) ( Fig. 1; Table 5 ). There was no LPS challenge 3 diet interaction observed for jejunal TNFa, PGE 2 , and caspase-3 or for ileal TNFa, PGE 2 , and HSP70. However, the pigs fed the fish oil diet had lower jejunal TNFa concentration (P < 0.05), caspase-3 protein expression (P < jn.nutrition.org 0.05), and ileal HSP70 protein expression (P < 0.05) compared with pigs fed the corn oil diet. Fish oil tended to decrease the jejunal PGE 2 concentration more than corn oil (P = 0.06). There was an LPS challenge 3 diet interaction observed for jejunal HSP70 (P < 0.01) and a trend for a LPS challenge 3 diet interaction observed for ileal caspase-3 (P = 0.08) such that the responses of these variables to the LPS challenge were lower in those pigs receiving the fish oil diet compared with the LPSchallenged pigs fed the corn oil diet, whereas there was no difference in these variables in the saline-injected pigs.
TLR4, MyD88, IRAK1, and TRAF6 mRNA expression. The pigs challenged with LPS had a higher mRNA abundance ( Table  6 ) of jejunal TLR4 (P < 0.05), ileal TLR4 (P < 0.01), and TNFa 1 Values are mean and pooled SE, n = 6 (1 pig/pen). Labeled means in a row without a common letter differ, P , 0.05. 2 The intestinal mucosa fatty acid profiles from 4:0 to 24:1(n-9) were analyzed in duplicate. Only the major fatty acids are listed. 3 Total (n-6) PUFA and total (n-3) PUFA corresponded to the sum of all the (n-6) or (n-3) PUFA detected. receptor-associated factor 6 (TRAF6) (P < 0.01) and tended to have a higher mRNA abundance of jejunal TRAF6 (P = 0.07) compared with pigs injected with saline. There was an LPS challenge 3 diet interaction observed for jejunal TLR4 (P < 0.05) and ileal IL-1 receptor-associated kinase 1 (IRAK1) (P < 0.05) and a trend for an LPS challenge 3 diet interaction for jejunal myeloid differentiation factor 88 (MyD88) (P = 0.08), TRAF6 (P = 0.09), and ileal TLR4 (P = 0.06) such that the responses of these variables to an LPS challenge were lower in those pigs receiving the fish oil diet compared with the LPSchallenged pigs fed the corn oil diet, whereas these variables did not differ in saline-injected pigs. There was no LPS challenge 3 diet interaction observed for jejunal IRAK1 and ileal TRAF6.
However, the pigs fed the fish oil diet had lower jejunal IRAK1 (P < 0.05) mRNA abundance and tended to have lower ileal TRAF6 (P = 0.06) mRNA abundance compared with those fed the corn oil diet. Neither LPS nor diet had an effect on ileal MyD88 mRNA abundance.
NOD1, NOD2, and RIPK2 mRNA expression. The pigs challenged with LPS had higher NOD2 and receptor-interacting serine/threonine-protein kinase 2 (RIPK2) mRNA abundance in jejunum and ileum (P < 0.01) ( Table 6 ) compared with those injected with saline. An LPS challenge 3 diet interaction was observed for jejunal NOD2 and RIPK2 and ileal NOD2 (P < 0.05) in which pigs fed fish oil had lower jejunal NOD2 and RIPK2 and ileal NOD2 compared with pigs fed corn oil among LPS-treated pigs, whereas these variables did not differ among saline-treated pigs. No diet or LPS challenge effect was observed for jejunal and ileal NOD1 mRNA abundance.
mRNA and protein expression of NFkB p65. Neither diet nor LPS challenge had an effect on NFkB p65 mRNA abundance (Table 6 ). However, pigs challenged with LPS had higher NFkB p65 protein expression in jejunum and ileum (P < 0.05) than those injected with saline ( Fig. 1 ; Table 5 ). There was no LPS challenge 3 diet interaction observed for NFkB p65 protein expression. The pigs fed the fish oil diet had lower ileal NFkB p65 protein expression compared with those fed the corn oil diet (P < 0.05).
Discussion
Fish oil is an important source of (n-3) PUFA such as EPA and DHA and exerts beneficial effects on inflammatory bowel diseases in animal models and clinical trials (6) . Based on this, we investigated the protective effect of 5% fish oil on intestinal morphology and barrier function after a 4-h Escherichia coli LPS challenge using a piglet model. In our study, expectedly, dietary and intestinal mucosa fatty acid profile analysis demonstrated that dietary supplementation of 5% fish oil resulted in enrichment of EPA, DHA, and total (n-3) PUFA in intestinal mucosa. Villus height, crypt depth, and VCR serve as criteria that reflect gross intestinal morphology (16) . In the current experiment, the LPS challenge decreased jejunal and ileal villus height and jejunal VCR and tended to decrease ileal VCR at 4 h postchallenge, which suggests that LPS caused acute intestinal mucosa damage. Our data are similar to the results of Touchette (26) and Mercer et al. (24) . Independent of LPS challenge, fish oil increased jejunal and ileal villus height and VCR and tended to increase jejunal VCR relative to the corn oil diet, which indicates that fish oil improved intestinal morphology. Similar to our findings, Nieto et al. (19) found that the diet enriched in fish oil attenuated macroscopic and microscopic colonic injury in rats with experimental ulcerative colitis. An intact intestinal barrier plays a central role in preventing the penetration by luminal bacteria and dietary allergens into the mucosa (1). Intestinal barrier function can be commonly assessed by many indices such as DAO activity (30), transepithelial resistance (33) , and intestine mucosal permeability (33) . In the current experiment, consistent with improved intestinal morphology, fish oil improved intestinal barrier function, indicated by decreased plasma DAO activity and increased jejunal DAO activity, compared with corn oil. Our observations were supported by Willemsen et al. (33) and Li et al. (34) , who reported that EPA and DHA supported epithelial barrier integrity by improving transepithelial electrical resistance and reducing cytokine-mediated permeability of human intestinal epithelial cells (T84). Moreover, Jacobi et al. (35) also showed that dietary supplementation of 5% EPA enhanced transepithelial electrical resistance in ischemic-injured ileum of suckling pigs.
The major components of intestinal barrier function are mainly determined by tight junctions between epithelial cells (36) . Tight junctions are composed of 40 different proteins. Of them, occludin and claudins are thought of as the major integral membrane proteins, which participate in tight junction structural integrity by binding to the actin cytoskeleton (37) . In the current experiment, consistent with the improved intestinal barrier function, fish oil enhanced the protein expression of jejunal occludin and ileal claudin-1 and tended to increase that of ileal occluding independent of LPS challenge. Similarly, Li et al. (36) reported that fish oil protected against altered membrane microdomain localization of tight junction proteins; increased the expression of zonula occludens-1, claudin-1, claudin-5, and claudin-8; and attenuated the disruption of tight junction structure and thus alleviated mucosa injury in rat colitis caused by 2,4,6-trinitrobenzenesulfonic acid. In our present study, fish oil may partially improve the intestinal barrier function via improving the expression of intestinal tight junction proteins. We hypothesized that fish oil exerts its beneficial effect on the intestine by alleviating the intestinal inflammatory response. Similar to TNFa and PGE 2 , a high level of HSP70 and caspase-3 are also markers of inflammatory response in intestine (31, 38) . In the current experiment, consistent with improved intestinal integrity, dietary fish oil supplementation decreased the TNFa concentration in jejunum and HSP70 and caspase 3 protein expressions in jejunum and ileum and tended to decrease the PGE 2 concentration in jejunum. Currently, there is an abundance of research on the modulation of intestinal proinflammatory mediators through dietary supplementation of (n-3) PUFA. Calder et al. (6) (7) (8) reported that the protective role of (n-3) PUFA in inflammatory bowel diseases is partially due to their inhibitory effects on the overproduction of proinflammatory mediators, including proinflammatory cytokines and inflammatory eicosanoids (e.g., PGE 2 ). So, in our current study, feeding pigs with a fish oil diet may improve intestinal integrity partially by inhibiting the production of proinflammatory mediators.
To elucidate the molecular mechanism(s) by which fish oil might attenuate the intestinal inflammatory response, we examined the role of the TLR4 signaling pathway. TLR are an ancient conserved family of pattern-recognition receptors that plays a critical role in recognizing microbial pathogens and modulating antimicrobial host defense (39) . Among this family, TLR4 is the best-characterized member. TLR4 is responsible for recognizing endotoxin or LPS from Gram-negative bacteria and initiating the systemic inflammatory response syndrome (39, 40) . When engaged by LPS, the TLR4/MD-2/CD14 receptor complex delivers a signal detected by MyD88, which is passed onwards by a series of IRAK, TRAF6, and NFkB inducing kinase and activation of transcription factors such as NFkB, resulting in activation of the inflammatory genes such as proinflammatory cytokines and cycloxygenase (COX) 2 (39). TLR4 signaling has been shown to be involved in intestinal inflammation (14) . In the current study, we observed that intestinal mRNA abundances of TLR4 and its downstream signals, including MyD88, IRAK1, and TRAF6, were decreased and the production of intestinal TNFa was simultaneously reduced in the pigs fed the fish oil-supplemented diet after the LPS challenge. Surprisingly, mRNA expression of NFkB p65 was not affected by LPS and fish oil. However, further protein expression analysis showed that NFkB p65 protein expression was upregulated by the LPS challenge and downregulated by fish oil. Until now, the research on (n-3) PUFA modulating TLR signaling was limited to using in vitro cell models such as monocyte/macrophage cells, and the data in vivo are very limited. Lee et al. (41, 42) reported that SFA such as lauric acid stimulated, but (n-3) PUFA such as EPA or DHA inhibited, TLR4 activation and the expression of target genes in monocyte/macrophage cells (RAW 264.7). Most recently, Wong et al. (43) demonstrated that treatment of macrophages with lauric acid induced dimerization and recruitment of TLR4, MyD88, and other signaling proteins into membrane rafts in a reactive oxygen species-dependent manner, whereas (n-3) PUFA (DHA) inhibited the processes. In our current study, it is possible the protective effects of fish oil supplementation on intestinal integrity were closely related to reducing the expression of intestinal proinflammatory cytokines through inhibiting the TLR4 signaling pathway.
Apart from TLR, a critical role in recognizing PAMP and regulating the innate immune response is also played by other pattern recognition receptors such as cytoplasmic NOD proteins (13, 44) . NOD possess the ability to connect with the bacterial LPS and peptidoglycan and to deliver a TLR-independent signal, which also results in NFkB activation via RIPK2 and stimulates the expression of proinflammatory cytokines, adhesive molecules, etc. (13) . Research has shown that NOD play an important role in intestinal inflammation (15) . Though LPS is not a ligand for NOD1 and NOD2, NOD1 and NOD2 have been shown to be activated by LPS through TLR4 and TNFa (45) . In the present study, similar to the TLR4 signaling pathway, we also observed that intestinal mRNA abundances of NOD2 and its adaptor molecule RIPK2 were decreased in fish oil-supplemented pigs after LPS challenge. The research on (n-3) PUFA regulating NOD signaling is very limited. Research from Zhao et al. (46) showed that SFA (lauric acid) stimulated, but PUFA, particularly (n-3) PUFA (EPA or DHA), inhibited, NOD signaling pathways in human colonic epithelial HCT116 cells. In our study, it is possible that the protective effects of fish oil on intestinal integrity are also related to reducing the expression of intestinal proinflammatory cytokines via inhibition of the NOD2 signaling pathway.
In our current study, regretfully, only one time-point (4 h) was chosen for intestinal sample collection. It might not be the most appropriate time point to measure all of the intestinal proinflammatory mediators and signaling molecules following the LPS challenge, because some variables were not significantly affected by LPS, or the LPS-induced increases of some variables were small at this time point. If we had more time points for intestinal sample collection to analyze the dynamic changes in these proinflammatory mediators as well as signaling molecules in both mRNA and protein levels, adequate information would be provided to confirm their roles in LPS-induced intestinal injury, which awaits further experiments. In addition, our data showed that fish oil improved intestinal integrity not only on inflammatory condition but also on normal condition, but exerted a significant effect on some of the proinflammatory mediators and signaling molecules only on the inflammatory condition. The inconsistency between them indicates that there are other possible mechanisms by which fish oil improves the intestinal integrity, except via influencing TLR4 and NOD2 signaling pathways.
In summary, fish oil supplementation exerts beneficial effects in improving intestinal integrity. It is possible that the protective effects of fish oil on the intestine are closely related to reducing the expression of intestinal proinflammatory cytokines via inhibition of the TLR4 and NOD2 signaling pathways.
